Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
Loke J, Labopin M, Craddock C, Cornelissen JJ, Labussière-Wallet H, Wagner-Drouet EM, Van Gorkom G, Schaap NPM, Kröger NM, Veelken JH, Rovira M, Menard AL, Bug G, Bazarbachi A, Giebel S, Brissot E, Nagler A, Esteve J, Mohty M.
Loke J, et al.
Cancer. 2022 Aug 1;128(15):2922-2931. doi: 10.1002/cncr.34268. Epub 2022 May 25.
Cancer. 2022.
PMID: 35612815
Free PMC article.